Get In Touch

Recognized Leader for Drug & Device Strategy

NOVEL Health Strategies is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access. NOVEL's team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. NOVEL has large network of internal and external stakeholders and has published several thought leading strategy perspectives.

Our Team in News

During 2011-2016 NOVEL's team was interviewed and quoted by The New York Times, Scientific American, Fast Company and Nature Medicine.

Read More

Our Publications

Our team has published over 200 studies in healthcare. These studies have been cited by hundreds of publications.

Read More

Our Presentations

We have presented trends, views and studies at conferences, federal agency meetings and special workshops.

Read More

AWARD Winning Study on Market Access Trends by NOVEL

NOVEL's team recently conducted a comprehensive study on market access trends of Top 100 selling drugs. This study won PLATINUM medal by AMCP and was also nominated by ISPOR as award finalist.

Read More

NOVEL Selected for 26 Presentations at ISPOR and AMCP 2016

NOVEL was selected for 26 peer-reviewed presentations at ISPOR and AMCP conferences. NOVEL was also selected for PODIUM session and nominated for TWO AWARDS.

Read More

NOVEL Wins Another PLATINUM Medal Award at AMCP

NOVEL's team won Platinum Medal Award for Presentation on Managed Care Trends at AMCP Nexus Educational Conference in Orlando

Read More

NOVEL Health Strategies Selected for 16 Presentations at ISPOR Milan

NOVEL has been selected for 16 peer-reviewed presentations at ISPOR 2015 meeting in Milan. Released PDFs PROBIOTICS NMA , EHB MARKET ACCESS, STROKE NMA , ACA. Two of the Presentations Won Poster Award Finalist Honor.

Read More

NOVEL Won Two Platinum and Bronze Medal Awards at AMCP

NOVEL's team won two Platinum and Bronze Medal Awards for Presentations at AMCP Nexus Educational Conference in Boston

Read More

NOVEL Health Strategies & US Payers Panel on Biosimilars June 3-4, 2015

NOVEL and top US payers will be discussing strategies, issues and challenges for Biosimilars on June 3-4 in Philadelphia. Download Agenda and Speakers List

Read More

NOVEL Selected for Presentations at AMCP

NOVEL's team was selected for multiple presentations at AMCP. NOVEL is also teaching an educational course on Breakthrough Therapies (CPE credit course). NOVEL also won two Platinum and Bronze Medal Awards!

Read More

Podium & Poster Presentations at ISPOR 2015, Philadelphia

NOVEL has been selected for 10 peer-reviewed presentations at ISPOR 2015 meeting in Philadelphia. PDF of our PODIUM presentation is available at ISPOR website.

Read More

Strategy Overview on Breakthrough Therapy Designations (Nature Biotech)

NOVEL just published a comprehensive overview on all Breakthrough Therapy Designated products, covering their clinical, HEOR, comparative effectiveness and market access. This study was published in Nature Biotechnology (Journal Impact Factor 39.1, among top most cited journals in science and medicine).

Read More

Podium & Poster Presentations at HTAi DC

At the Health Technology Assessment HTAi Annual Meeting in Washington, DC, NOVEL's team was selected for podium and poster presentations.

Read More

Annual Strategy Perspective in Nature Biotechnology

Our annual strategy series has been cited and quoted more than two hundred times. These series were published in Nature Biotechnology (Journal Impact Factor 39.1, among top most cited journals in science and medicine).

Read More

Market Access & Reimbursement Strategy Seminar in Copenhagen

NOVEL's team and leading healthcare stakeholders hosted a one-day workshop on Market Access & Reimbursement Strategy in Copenhagen (Ministry of Foreign Affairs, Denmark).

Read More